🇺🇸 FDA
Patent

US 9982259

Transthyretin allele selective UNA oligomers for gene silencing

granted A61KA61K31/685A61K31/713

Quick answer

US patent 9982259 (Transthyretin allele selective UNA oligomers for gene silencing) held by ARCTURUS THERAPEUTICS, INC. expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARCTURUS THERAPEUTICS, INC.
Grant date
Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/685, A61K31/713, A61K9/127, A61P